XML 18 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid In Capital
Cumulative Net Income (Loss)
Cumulative Distributions
Beginning balance (in shares) at Dec. 31, 2018   3,179,000      
Beginning balance at Dec. 31, 2018 $ 59,668 $ 32 $ 62,540 $ (2,904) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share grants 35   35    
Net income 578     578  
Distributions (350)       (350)
Ending balance (in shares) at Mar. 31, 2019   3,179,000      
Ending balance at Mar. 31, 2019 59,931 $ 32 62,575 (2,326) (350)
Beginning balance (in shares) at Dec. 31, 2018   3,179,000      
Beginning balance at Dec. 31, 2018 59,668 $ 32 62,540 (2,904) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 3,528        
Ending balance (in shares) at Sep. 30, 2019   8,240,000      
Ending balance at Sep. 30, 2019 86,679 $ 82 88,827 624 (2,854)
Beginning balance (in shares) at Mar. 31, 2019   3,179,000      
Beginning balance at Mar. 31, 2019 59,931 $ 32 62,575 (2,326) (350)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share grants (in shares)   15,000      
Share grants 185   185    
Share repurchases (in shares)   (1,000)      
Share repurchases (6)   (6)    
Net income 894     894  
Distributions (702)       (702)
Issuance of shares, net (in shares)   5,000,000      
Issuance of shares, net 26,074 $ 50 26,024    
Ending balance (in shares) at Jun. 30, 2019   8,193,000      
Ending balance at Jun. 30, 2019 86,376 $ 82 88,778 (1,432) (1,052)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share grants (in shares)   53,000      
Share grants 80   80    
Share repurchases (in shares)   (6,000)      
Share repurchases (31)   (31)    
Net income 2,056     2,056  
Distributions (1,802)       (1,802)
Ending balance (in shares) at Sep. 30, 2019   8,240,000      
Ending balance at Sep. 30, 2019 $ 86,679 $ 82 88,827 624 (2,854)
Beginning balance (in shares) at Dec. 31, 2019 8,239,610 8,240,000      
Beginning balance at Dec. 31, 2019 $ 86,221 $ 82 88,869 1,937 (4,667)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share grants 42   42    
Share repurchases (in shares)   (1,000)      
Share repurchases (2)   (2)    
Net income 1,666     1,666  
Distributions (1,895)       (1,895)
Ending balance (in shares) at Mar. 31, 2020   8,239,000      
Ending balance at Mar. 31, 2020 $ 86,032 $ 82 88,909 3,603 (6,562)
Beginning balance (in shares) at Dec. 31, 2019 8,239,610 8,240,000      
Beginning balance at Dec. 31, 2019 $ 86,221 $ 82 88,869 1,937 (4,667)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 6,653        
Distributions $ (1,978)        
Ending balance (in shares) at Sep. 30, 2020 8,303,254 8,303,000      
Ending balance at Sep. 30, 2020 $ 91,063 $ 83 89,035 8,590 (6,645)
Beginning balance (in shares) at Mar. 31, 2020   8,239,000      
Beginning balance at Mar. 31, 2020 86,032 $ 82 88,909 3,603 (6,562)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share grants (in shares)   15,000      
Share grants 72 $ 1 71    
Share repurchases (1)   (1)    
Net income 2,362     2,362  
Ending balance (in shares) at Jun. 30, 2020   8,254,000      
Ending balance at Jun. 30, 2020 88,465 $ 83 88,979 5,965 (6,562)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share grants (in shares)   56,000      
Share grants 76   76    
Share repurchases (in shares)   (7,000)      
Share repurchases (20)   (20)    
Net income 2,625     2,625  
Distributions $ (83)       (83)
Ending balance (in shares) at Sep. 30, 2020 8,303,254 8,303,000      
Ending balance at Sep. 30, 2020 $ 91,063 $ 83 $ 89,035 $ 8,590 $ (6,645)